Q: What is Bremelanotide (PT-141)?
A: Bremelanotide is a melanocortin receptor agonist available by prescription. An FDA-approved bremelanotide product is indicated for certain premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). Our licensed healthcare providers will determine whether treatment is medically appropriate based on an individual evaluation.
Q: How is Bremelanotide administered?
A: Bremelanotide is administered by subcutaneous injection. Patients should follow the individualized dosing, timing, and administration instructions provided by our medical team and dispensing pharmacy.
Q: When should Bremelanotide be used?
A: Bremelanotide should be used only according to the timing and frequency prescribed by our licensed healthcare providers. Instructions may vary depending on the prescribed formulation and individual treatment plan.
Q: What results can I expect?
A: Individual responses vary, and specific results cannot be guaranteed. Our medical team will discuss treatment goals and may monitor your response to determine whether continued treatment is appropriate.
Q: Is Bremelanotide safe?
A: Bremelanotide may cause side effects and is not appropriate for everyone. Potential side effects can include nausea, flushing, headache, vomiting, injection-site reactions, and temporary increases in blood pressure. Our licensed healthcare providers will review relevant health history, medications, potential risks, and contraindications before determining whether treatment is appropriate.
Q: Who should not use Bremelanotide?
A: Bremelanotide may not be appropriate for patients with certain medical conditions, including uncontrolled high blood pressure or known cardiovascular disease. Our licensed healthcare providers will evaluate relevant health information before prescribing treatment.
Q: Why is a medical evaluation required?
A: Our medical evaluation allows a licensed healthcare provider to review symptoms, health history, current medications, potential contraindications, and treatment options before determining whether Bremelanotide is medically appropriate.
Q: Is this compounded formulation FDA-approved?
A: No. Compounded medications are not FDA-approved. When clinically appropriate, our licensed healthcare providers may prescribe a compounded formulation for an individual patient. The dispensing pharmacy provides formulation-specific information and instructions.